{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:59:12Z","timestamp":1792144752183,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Child Psychiatry Hum Dev"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10578-022-01424-6","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:02:37Z","timestamp":1662444157000},"page":"479-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence"],"prefix":"10.1007","volume":"55","author":[{"given":"Wisam","family":"Al Jumaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Muzwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Durga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Al Jumaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/NDT.S113099","volume":"13","author":"M Dayabandara","year":"2017","unstructured":"Dayabandara M et al (2017) Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat 13:2231\u20132241. https:\/\/doi.org\/10.2147\/NDT.S113099","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"1424_CR2","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1176\/ajp.2006.163.12.2072","volume":"163","author":"DJ Klein","year":"2006","unstructured":"Klein DJ et al (2006) A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. Am J Psychiatry. 163(12):2072\u20132079. https:\/\/doi.org\/10.1176\/ajp.2006.163.12.2072","journal-title":"Am J Psychiatry."},{"issue":"4","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/jamapsychiatry.2020.4180","volume":"78","author":"BI Perry","year":"2021","unstructured":"Perry BI et al (2021) Longitudinal trends in childhood insulin levels and body mass index and associations with risks of psychosis and depression in young adults. JAMA Psychiatry 78(4):416\u2013425. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.4180","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10673220802073915","volume":"16","author":"L Shin","year":"2008","unstructured":"Shin L et al (2008) Overview of obesity in children with psychiatric disorders taking atypical antipsychotics 2008. Harv Rev Psychiatry 16(2):69\u201379. https:\/\/doi.org\/10.1080\/10673220802073915","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4088\/pcc.v02n0601","volume":"2","author":"RJ Leo","year":"2000","unstructured":"Leo RJ et al (2000) Atypical antipsychotic use in the treatment of psychosis in primary care prim care companion. J Clin Psychiatry. 2(6):194\u2013204. https:\/\/doi.org\/10.4088\/pcc.v02n0601","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"1424_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/cap.2011.0015","volume":"21","author":"L Maayan","year":"2011","unstructured":"Maayan L et al (2011) Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. Child Adolesc Psychopharmacol. 21(6):517\u2013535. https:\/\/doi.org\/10.1089\/cap.2011.0015","journal-title":"Child Adolesc Psychopharmacol."},{"issue":"8","key":"1424_CR7","first-page":"1130","volume":"29","author":"S Arman","year":"2008","unstructured":"Arman S et al (2008) Randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents. Saudi Med J. 29(8):1130\u20131134","journal-title":"Saudi Med J."},{"issue":"9","key":"1424_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/jamapsychiatry.1232","volume":"73","author":"E Anagnostou","year":"2016","unstructured":"Anagnostou E et al (2016) Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: a randomized clinical trial. JAMA Psychiatry. 73(9):928\u2013937. https:\/\/doi.org\/10.1001\/jamapsychiatry.1232","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"1424_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/wps.20714","volume":"19","author":"CU Correll","year":"2020","unstructured":"Correll CU et al (2020) Metformin add-on vs antipsychotic switch vs continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. World Psychiatry. 19(1):69\u201380. https:\/\/doi.org\/10.1002\/wps.20714","journal-title":"World Psychiatry."},{"issue":"3","key":"1424_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.braindev.2004.06.006","volume":"27","author":"R Canitano","year":"2005","unstructured":"Canitano R et al (2005) Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders. Brain Dev. 27(3):228\u2013232. https:\/\/doi.org\/10.1016\/j.braindev.2004.06.006","journal-title":"Brain Dev."},{"issue":"4","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1345\/aph.1M550","volume":"44","author":"LK Ellinger","year":"2010","unstructured":"Ellinger LK et al (2010) Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain 2010. Ann Pharmacother 44(4):668\u2013679. https:\/\/doi.org\/10.1345\/aph.1M550","journal-title":"Ann Pharmacother"},{"key":"1424_CR12","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020844s041lbl.pdf"},{"issue":"3","key":"1424_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/104454602760386941","volume":"12","author":"BL Gracious","year":"2002","unstructured":"Gracious BL et al (2002) Amantadine treatment of psychotropic-induced weight gain in children and adolescents: case series. Case Rep J Child Adolesc Psychopharmacol Fall 12(3):249\u2013257. https:\/\/doi.org\/10.1089\/104454602760386941","journal-title":"Case Rep J Child Adolesc Psychopharmacol Fall"},{"key":"1424_CR14","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016023s041,018101s016lbl.pdf"},{"issue":"12","key":"1424_CR15","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1007\/s00213-018-5079-1","volume":"235","author":"RC Smith","year":"2018","unstructured":"Smith RC et al (2018) Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study. Psychopharmacol (Berl). 235(12):3545\u20133558. https:\/\/doi.org\/10.1007\/s00213-018-5079-1","journal-title":"Psychopharmacol (Berl)."},{"issue":"5","key":"1424_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1089\/cap.2016.0046","volume":"27","author":"Seyed-Ali Mostafavi","year":"2017","unstructured":"Mostafavi Seyed-Ali et al (2017) Melatonin for reducing weight gain following administration of atypical antipsychotic olanzapine for adolescents with bipolar disorder: a randomized double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 27(5):440\u2013444. https:\/\/doi.org\/10.1089\/cap.2016.0046","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"1424_CR17","volume-title":"Melatonin","author":"RA Savage","year":"2020","unstructured":"Savage RA et al (2020) Melatonin. Stat Pearls Publishing, Tampa"},{"key":"1424_CR18","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/206321s007lbl.pdf"},{"issue":"7","key":"1424_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","volume":"74","author":"JR Larsen","year":"2017","unstructured":"Larsen JR et al (2017) Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder a randomized clinical trial JAMA. Psychiatry 74(7):719\u2013728. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.1220","journal-title":"Psychiatry"},{"key":"1424_CR20","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/085128s065lbl.pdf"},{"issue":"1","key":"1424_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ijo.2016.185","volume":"41","author":"JR Ryder","year":"2017","unstructured":"Ryder JR et al (2017) Effect of phentermine on weight reduction in a pediatric weight management clinic. Int J Obes (Lond) 41(1):90\u201393. https:\/\/doi.org\/10.1038\/ijo.2016.185","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"1424_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.9758\/cpn.2013.11.1.7","volume":"11","author":"AN Hoyoung","year":"2013","unstructured":"Hoyoung AN et al (2013) Phentermine. Sibutramine and affective disorders. Clin Psychopharmacol Neurosci 11(1):7\u201312. https:\/\/doi.org\/10.9758\/cpn.2013.11.1.7","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"7","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.biopsych.2008.10.037","volume":"65","author":"JL Roeri","year":"2009","unstructured":"Roeri JL et al (2009) An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects. Biol Psychiatry. 65(7):607\u2013613. https:\/\/doi.org\/10.1016\/j.biopsych.2008.10.037","journal-title":"Biol Psychiatry."},{"issue":"1","key":"1424_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3371\/CSRP.5.1.3","volume":"5","author":"M Patricia Ball","year":"2011","unstructured":"Patricia Ball M et al (2011) Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine. Clin Schizophr Relat Psychoses 5(1):17\u201325. https:\/\/doi.org\/10.3371\/CSRP.5.1.3","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"1424_CR25","first-page":"300","volume":"2011","author":"BU Nwosu","year":"2011","unstructured":"Nwosu BU et al (2011) A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects second-generation antipsychotics. JPEM 2011:300","journal-title":"JPEM"},{"key":"1424_CR26","unstructured":"https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-and-press-announcements-ndma-metformin"},{"issue":"1","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/0253-7176.96168","volume":"34","author":"V Shivakumar","year":"2012","unstructured":"Shivakumar V et al (2012) Successful use of add - on topiramate for antipsychotic - induced weight gain. Indian J Psychol Med. 34(1):85\u201386. https:\/\/doi.org\/10.4103\/0253-7176.96168","journal-title":"Indian J Psychol Med."},{"issue":"1","key":"1424_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0091217415621266","volume":"51","author":"M Shapiro","year":"2016","unstructured":"Shapiro M et al (2016) Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications. Int J Psychiatry Med 51(1):56\u201368. https:\/\/doi.org\/10.1177\/0091217415621266","journal-title":"Int J Psychiatry Med"},{"issue":"4","key":"1424_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/2045125312440441","volume":"2","author":"SK Praharaj","year":"2012","unstructured":"Praharaj SK et al (2012) Amantadine for olanzapine-induced weight gain: a systematic review and meta-analysis of randomized placebo-controlled trials. Ther Adv Psychopharmacol 2(4):151\u2013156. https:\/\/doi.org\/10.1177\/2045125312440441","journal-title":"Ther Adv Psychopharmacol"},{"key":"1424_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fpsyt.2018.00620","volume":"9","author":"D Kang","year":"2018","unstructured":"Kang D et al (2018) Effect of betahistine and metformin on antipsychotic-induced weight gain: an analysis of two clinical trials. Front Psychiatry 9:620. https:\/\/doi.org\/10.3389\/fpsyt.2018.00620","journal-title":"Front Psychiatry"},{"issue":"12","key":"1424_CR31","doi-asserted-by":"publisher","first-page":"623681","DOI":"10.3389\/fpsyt.2021.623681","volume":"12","author":"Libowitz","year":"2021","unstructured":"Libowitz et al (2021) The burden of antipsychotic-induced weight gain and metabolic syndrome in children. Front Psychiatry 12(12):623681. https:\/\/doi.org\/10.3389\/fpsyt.2021.623681","journal-title":"Front Psychiatry"},{"key":"1424_CR32","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020766s029lbl.pdf"},{"issue":"5","key":"1424_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.4088\/JCP.v69n0503","volume":"69","author":"G Joffe","year":"2008","unstructured":"Joffe G et al (2008) Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69(5):706\u2013711","journal-title":"J Clin Psychiatry"},{"key":"1424_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1753-2000-6-21","volume":"6","author":"CA Calargeet","year":"2012","unstructured":"Calargeet CA et al (2012) Correlates of weight gain during long-term Risperidone treatment in children and adolescents. Child Adolesc Psychiatry Ment Health. 6:21. https:\/\/doi.org\/10.1186\/1753-2000-6-21","journal-title":"Child Adolesc Psychiatry Ment Health."}],"container-title":["Child Psychiatry & Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10578-022-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10578-022-01424-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10578-022-01424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T03:15:09Z","timestamp":1708744509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10578-022-01424-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s10578-022-01424-6","relation":{},"ISSN":["0009-398X","1573-3327"],"issn-type":[{"value":"0009-398X","type":"print"},{"value":"1573-3327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"22 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}